Cargando…
Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus
Neuraminidase is the main target for current influenza drugs. Reduced susceptibility to oseltamivir, the most widely prescribed neuraminidase inhibitor, has been repeatedly reported. The resistance substitutions I223V and S247N, alone or in combination with the major oseltamivir-resistance mutation...
Autores principales: | Pokorná, Jana, Pachl, Petr, Karlukova, Elena, Hejdánek, Jakub, Řezáčová, Pavlína, Machara, Aleš, Hudlický, Jason, Konvalinka, Jan, Kožíšek, Milan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071225/ https://www.ncbi.nlm.nih.gov/pubmed/29933553 http://dx.doi.org/10.3390/v10070339 |
Ejemplares similares
-
DNA-linked inhibitor antibody assay (DIANA) as a new method for screening influenza neuraminidase inhibitors
por: Kožíšek, Milan, et al.
Publicado: (2018) -
Current and Novel Inhibitors of HIV Protease
por: Pokorná, Jana, et al.
Publicado: (2009) -
Synthesis and In Vitro Evaluation of C-7 and C-8 Luteolin Derivatives as Influenza Endonuclease Inhibitors
por: Reiberger, Robert, et al.
Publicado: (2021) -
Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia
por: Hnízda, Aleš, et al.
Publicado: (2016) -
Thermodynamic characterization of the peptide assembly inhibitor binding to HIV-1 capsid protein
por: Kozisek, Milan, et al.
Publicado: (2013)